Report #2865790

Received Oct 14, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: Sep 25, 2025
Onset: Sep 1, 2025
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RVX	ROTAVIRUS (NO BRAND NAME)	UNKNOWN MANUFACTURER	UNK	UNK	—

Symptoms (1)

Skin disorder

Symptom narrative

spots on my body; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of papule in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On 25-SEP-2025, the patient received RSV vaccine. In SEP-2025, less than a week after receiving RSV vaccine, the patient experienced papule (Verbatim: spots on my body). The outcome of the papule was not reported. It was unknown if the reporter considered the papule to be related to RSV vaccine. It was unknown if the company considered the papule to be related to RSV vaccine. Additional Information: GSK Receipt Date: 30-SEP-2025 This case was reported by a patient via interactive digital media. The patient got RSV shot and had sure spots of the body